301 related articles for article (PubMed ID: 36510158)
21. Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome.
Piñana JL; Martino R; Barba P; Bellido-Casado J; Valcárcel D; Sureda A; Briones J; Brunet S; Rodriguez-Arias JM; Casan P; Sierra J
Am J Hematol; 2012 Jan; 87(1):9-14. PubMed ID: 22031451
[TBL] [Abstract][Full Text] [Related]
22. Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Huang QS; Han TX; Chen Q; Wu J; Zhao P; Wu YJ; He Y; Zhu XL; Fu HX; Wang FR; Zhang YY; Mo XD; Han W; Yan CH; Wang JZ; Chen H; Chen YH; Han TT; Lv M; Chen Y; Wang Y; Xu LP; Liu KY; Huang XJ; Zhang XH
Bone Marrow Transplant; 2024 Feb; 59(2):239-246. PubMed ID: 38012449
[TBL] [Abstract][Full Text] [Related]
23. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
24. Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors.
Myrdal OH; Aaløkken TM; Diep PP; Ruud E; Brinch L; Fosså K; Mangseth H; Kongerud J; Sikkeland LI; Lund MB
Respiration; 2022; 101(6):544-552. PubMed ID: 34937032
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
26. Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell Transplantation.
Shimomura Y; Kitamura T; Murata M; Matsuo K; Ito Y; Ichinohe T; Hashii Y; Goto H; Kato K; Ishimaru F; Sato A; Onizuka M; Yanagisawa A; Ohbiki M; Tabuchi K; Atsuta Y; Fukuda T; Kanda J; Terakura S
Transplant Cell Ther; 2024 Mar; 30(3):326.e1-326.e14. PubMed ID: 38218451
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation.
Inaba H; Yang J; Pan J; Stokes DC; Krasin MJ; Srinivasan A; Hartford CM; Pui CH; Leung W
Cancer; 2010 Apr; 116(8):2020-30. PubMed ID: 20186702
[TBL] [Abstract][Full Text] [Related]
28. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M
Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518
[TBL] [Abstract][Full Text] [Related]
29. The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Jung S; Yoon HM; Yoon J; Park M; Rhee ES; Kim H; Koh KN; Lee JS; Im HJ; Yu J
Pediatr Pulmonol; 2021 Oct; 56(10):3332-3341. PubMed ID: 34357700
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
[TBL] [Abstract][Full Text] [Related]
31. [Effects of chemotherapy combined with donor lymphocyte infusion on chronic graft-versus-host disease and prognosis in minimal residual disease positive patients after allogeneic hematopoietic stem cell transplantation].
Shi YX; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YY; Liu KY; Huang XJ; Mo XD
Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):713-719. PubMed ID: 31648470
[No Abstract] [Full Text] [Related]
32. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation.
Forslöw U; Mattsson J; Gustafsson T; Remberger M
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1214-21. PubMed ID: 21193056
[TBL] [Abstract][Full Text] [Related]
33. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.
Kwok WC; Liang BM; Lui MMS; Tam TCC; Sim JPY; Tse EWC; Leung AYH; Kwong YL; Lie AKW; Ip MSM; Lam DCL
Respirology; 2019 May; 24(5):459-466. PubMed ID: 30663178
[TBL] [Abstract][Full Text] [Related]
34. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
[TBL] [Abstract][Full Text] [Related]
35. Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients.
Lueck C; Tzalavras A; Wohlfarth P; Meedt E; Kiehl M; Turki AT; Hoeper MM; Eder M; Cserna J; Buchtele N; Wolff D; Schellongowski P; Beutel G; Liebregts T
Bone Marrow Transplant; 2023 Mar; 58(3):303-310. PubMed ID: 36496524
[TBL] [Abstract][Full Text] [Related]
36. Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use.
Sagou K; Ukai S; Adachi Y; Fukushima N; Ozeki K; Kohno A
Int J Hematol; 2019 Mar; 109(3):299-308. PubMed ID: 30604314
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation.
Milano F; Au MA; Boeckh MJ; Deeg HJ; Chien JW
Biol Blood Marrow Transplant; 2011 May; 17(5):703-9. PubMed ID: 20736078
[TBL] [Abstract][Full Text] [Related]
39. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
[No Abstract] [Full Text] [Related]
40. Monitoring lung function in patients with chronic graft versus host disease: a pilot study.
Rushton C; Burton CS; Goddard K; Basran AK; Alfred A
Br J Nurs; 2019 Oct; 28(18):1196-1200. PubMed ID: 31597050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
